Biographical Summary

Dr. Goodrich-Doctor received her undergraduate degree in Bioscience and Biotechnology from Drexel University, in Philadelphia, PA. She received a doctorate degree in Microbiology and Molecular Virology with an emphasis in retrovirology at the Thomas Jefferson University, in Philadelphia, PA. She conducted scientific research in several areas including immunology, genetics, and virology in both the private sector and in academia.

Dr. Goodrich-Doctor joined the Department of Health and Human Services (HHS) in 2004 as a Scientific Fellow in the HHS Emerging Leaders Program. As a fellow she completed rotations in the Office of the Secretary (OS) for HHS, the National Institutes of Health (NIH) and the Food and Drug Administration. These scientifically based rotations focused on biodefense, chemical defense, food defense, and the management and review of scientific programs. Dr. Goodrich-Doctor earned a distinguished NIH Director’s Award in 2007 for her contributions to the NIH’s toxic chemical counterterrorism research program.

After completion of the Emerging Leaders Program, Dr. Goodrich-Doctor joined the National Institutes of Allergy and Infectious Diseases (NIAID); a part of the NIH where she led the reorganization of the branch’s clinical trials tracking mechanisms and served as a program officer for research grants. In 2007, Dr. Goodrich-Doctor was commissioned into the U.S. Public Health Service Commissioned Corps. In that same year, her interest in biodefense, counterterrorism, and emerging infectious diseases led her to join the Biomedical Advanced Research and Development Authority within the OS. In this position she successfully served as co-chairperson for the Viral Hemorrhagic Fevers (VHF) Integrated Program Team which analyzed U.S. funding for VHF countermeasures and drafted a product development plan that provided funding recommendations to meet the U.S. requirements for VHF countermeasures. She continued to serve the OS as a International Policy Analyst within the Office of Global Affairs to assist with coordinating HHS’ international influenza activities related to: program development, implementation, and evaluation; strategic planning; and, global health policy analysis and development. Her efforts within the OS earned her a PHS Commendation Medal and an Outstanding Service Medal.

Dr. Goodrich-Doctor returned to NIAID in 2010 and currently served as a Deputy Branch Chief for the Strategic Planning and Evaluation Branch within the NIAID Office of the Director. Her main tasks are focused on science policy and overseeing scientific analysis of priority areas which inform decision making regarding scientific planning for the Institute. Her previous experience also enables her to serve as a NIAID representative on several agency and interagency working groups which discuss and provide recommendations on programmatic and policy issues to NIH and HHS senior leadership.

Dr. Goodrich-Doctor has been a member of the Black Commissioned Officers Advisory Group (BCOAG) since 2007 and was selected to serve as a Voting Member from 2012 – 2014. Dr. Goodrich-Doctor served as the 2013 BCOAG Chair-Elect, BCOAG Chair in 2014, and currently serves as Past-Chair and BCOAG Representative to the Minority Officers Liaison Council.